Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

TLA Targeted Immuno Therapies AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 300 More Arrow 1,332 Less Arrow 1,321
Financial expenses 830 Less Arrow 545 Less Arrow 487
Earnings before taxes -7,236 More Arrow -6,146 More Arrow -4,611
EBITDA -4,232 More Arrow -3,850 More Arrow -3,564
Total assets 19,936 More Arrow 19,945 More Arrow 21,573
Current assets 3,225 More Arrow 3,975 More Arrow 4,838
Current liabilities 26,590 Less Arrow 16,699 Less Arrow 11,914
Equity capital -14,886 More Arrow -7,611 More Arrow -1,593
- share capital 176 Less Arrow 175 More Arrow 191
Employees (average) 4 Equal arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -74.7% More Arrow -38.2% More Arrow -7.4%
Turnover per employee 75 More Arrow 333 Less Arrow 330
Profit as a percentage of turnover -2412.0% More Arrow -461.4% More Arrow -349.1%
Return on assets (ROA) -32.1% More Arrow -28.1% More Arrow -19.1%
Current ratio 12.1% More Arrow 23.8% More Arrow 40.6%
Return on equity (ROE) 48.6% More Arrow 80.8% More Arrow 289.5%
Change turnover -1,039 More Arrow 118 Less Arrow -10,290
Change turnover % -78% More Arrow 10% Less Arrow -89%
Chg. No. of employees 0 Equal arrow 0 Less Arrow -2
Chg. No. of employees % 0% Equal arrow 0% Less Arrow -33%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.